HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

Pradefovir

Experimental HBV Drug Pradefovir: Safety, Tolerability, Antiviral Activity, and Pharmacokinetics - 11/21/05

New Experimental HBV Drug Pradefovir from Valeant Pharmaceuticals Shows Promising 24-week Interim Results in Phase 2 Study - 7/22/05

Pradefovir, a New Agent for the Treatment of Chronic Hepatitis B - 4/22/05

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)